Global Hemostasis Valve Market Size Study & Forecast, by Type (Hemostasis Valve Y-Connectors, Double Y-Connector Hemostasis Valves), Application (Angiography, Angioplasty), End Use, and Regional Forecasts 2025-2035

The Global Hemostasis Valve Market is valued at approximately USD 0.18 billion in 2024 and is projected to expand at a CAGR of about 5.90% throughout the forecast period of 2025–2035. Hemostasis valves, essential components in interventional cardiology and radiology procedures, are engineered to prevent blood loss while enabling clinicians to manipulate guidewires, catheters, and other vascular-access devices safely. Built to uphold procedural precision and minimize contamination, these valves have evolved into indispensable tools that support the efficiency, sterility, and safety of minimally invasive interventions. The market’s expansion is chiefly driven by increasing cardiovascular procedure volumes, heightened prevalence of coronary artery disease, and accelerated adoption of advanced imaging-guided interventions across hospitals and specialized catheterization labs worldwide.

A significant rise in interventional procedures has amplified the demand for high-performance hemostasis valves throughout the healthcare ecosystem. As angiography and angioplasty continue to gain prominence as frontline treatments for diagnosing and resolving arterial blockages, healthcare providers increasingly rely on specialized valves to ensure seamless device navigation and effective pressure control. Moreover, the global burden of cardiovascular disease remains formidable—prompting higher investments into catheterization suites, imaging infrastructure, and device-based therapies, all of which inevitably drive the uptake of hemostasis valves. Although emerging non-invasive diagnostic technologies may moderate market momentum, rapid technological advancements in valve materials, ergonomic design improvements, and the integration of leak-proof mechanisms are poised to unlock new growth avenues between 2025 and 2035.

The detailed segments and sub-segments included in this report are:

By Type:
• Hemostasis Valve Y-Connectors
• Double Y-Connector Hemostasis Valves

By Application:
• Angiography
• Angioplasty

By End Use:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Hemostasis Valve Y-Connectors are expected to dominate the market landscape over the forecast period. Their dominance stems from widespread applicability across both diagnostic and therapeutic catheter-based procedures, where clinicians depend on their flexibility, strong seal integrity, and compatibility with a broad range of interventional instruments. As cardiology departments ramp up procedural throughput and refine their workflow protocols, Y-connectors have become a standard requirement because they streamline catheter exchanges while reducing procedural time. Double Y-Connectors, although a smaller segment, are witnessing rising attention for complex interventions requiring multiple access points.

From a revenue standpoint, angiography currently leads the market owing to its pervasive adoption as an essential diagnostic modality for cardiovascular disease. Hospitals worldwide continue to increase their angiographic capacities, supported by expanding reimbursement frameworks and rapid modernization of catheterization laboratories. In parallel, angioplasty is emerging as the fastest-growing application, primarily fueled by the increasing prevalence of coronary artery stenosis and the escalating demand for minimally invasive alternatives to open-heart surgery. While angiography maintains a strong revenue share today, angioplasty represents a critical future growth engine for device manufacturers.

Across regional markets, North America secured the leading share in 2024 and is expected to maintain its dominance in 2025, supported by advanced healthcare infrastructure, early adoption of innovative interventional technologies, and a high incidence of cardiovascular disease. The region’s robust reimbursement systems and strong presence of global medical device manufacturers further bolster market penetration. Meanwhile, Asia Pacific is poised to be the fastest-growing region, driven by rapid hospital infrastructure development, a surge in lifestyle-related heart disorders, and government-led initiatives to expand cardiovascular treatment capacities in populous nations such as China and India. Europe continues to represent a mature and technologically advanced market, while Latin America and the Middle East & Africa show promising growth potential due to improving healthcare access and rising investments in interventional cardiology.

Major market players included in this report are:
• Merit Medical Systems
• Teleflex Incorporated
• Boston Scientific Corporation
• Abbott Laboratories
• Terumo Corporation
• Cardinal Health
• B. Braun Melsungen AG
• Medtronic plc
• Cook Medical
• CONMED Corporation
• AngioDynamics
• Teleon Surgical
• Biosense Webster
• Penumbra Inc.
• ICU Medical, Inc.

Global Hemostasis Valve Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast Period – 2025–2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments and countries in recent years and to forecast values for the coming decade. The report integrates both qualitative and quantitative factors that shape industry performance across various regions. It also provides deep insights into the primary drivers and challenges that will influence future market trajectories. Additionally, the study highlights opportunities within emerging sub-markets for stakeholders seeking targeted investments, while offering an extensive examination of competitive dynamics and product portfolios of the leading market players. The detailed segments and sub-segments of the market are explained above.

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level insights for major regions.
• Competitive landscape overview with key player profiles.
• Analysis of core business strategies and recommendations for future market positioning.
• Assessment of market structure, including demand-side and supply-side dynamics.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more